New device aims to improve rib fracture repair

NCT ID NCT07485829

Recruiting now Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing the safety and performance of the RibFix Titan™ device, used to fix broken ribs or during chest wall surgery. Researchers will follow 54 adults for 90 days after surgery to see how well the device works and if any additional procedures are needed. Participants will also report how their pain and physical function change over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RibFix Titan™ device
What this could lead to: If successful, this could confirm that RibFix Titan™ is a safe and effective option for repairing broken ribs, improving recovery and quality of life.
What could go wrong: This is a small, single-center study with only 54 participants, so results may not apply to everyone. There is a risk of reoperation or complications from the device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RIB FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone fracture Rib Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RIB FRACTURE RIB FRACTURE MULTIPLE

Contacts and locations

Locations

Ascension St. Vincent Hospital
RECRUITING

Indianapolis, Indiana, 46260, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.